
Kevin M. Johnson
Examiner (ID: 17187)
| Most Active Art Unit | 1793 |
| Art Unit(s) | 1793, 1732 |
| Total Applications | 255 |
| Issued Applications | 85 |
| Pending Applications | 85 |
| Abandoned Applications | 85 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18938177
[patent_doc_number] => 20240033316
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-01
[patent_title] => SELF-ASSEMBLED NANOPARTICLE AND USE THEREOF FOR ANTI- ANGIOGENESIS
[patent_app_type] => utility
[patent_app_number] => 17/815195
[patent_app_country] => US
[patent_app_date] => 2022-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7599
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17815195
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/815195 | Self-assembled nanoparticle and use thereof for anti-angiogenesis | Jul 25, 2022 | Issued |
Array
(
[id] => 18418490
[patent_doc_number] => 20230172948
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => OCULAR IMPLANT MADE BY A DOUBLE EXTRUSION PROCES
[patent_app_type] => utility
[patent_app_number] => 17/812133
[patent_app_country] => US
[patent_app_date] => 2022-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3826
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17812133
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/812133 | OCULAR IMPLANT MADE BY A DOUBLE EXTRUSION PROCES | Jul 11, 2022 | Abandoned |
Array
(
[id] => 17895380
[patent_doc_number] => 20220305042
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => Drug Delivery Composition Comprising a Self-Assembled Gelator
[patent_app_type] => utility
[patent_app_number] => 17/839851
[patent_app_country] => US
[patent_app_date] => 2022-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19627
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17839851
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/839851 | Drug Delivery Composition Comprising a Self-Assembled Gelator | Jun 13, 2022 | Abandoned |
Array
(
[id] => 18383206
[patent_doc_number] => 11653969
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-23
[patent_title] => Methods of alleviating symptoms of ocular surface discomfort using medical ice slurry
[patent_app_type] => utility
[patent_app_number] => 17/839674
[patent_app_country] => US
[patent_app_date] => 2022-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 11
[patent_no_of_words] => 9675
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17839674
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/839674 | Methods of alleviating symptoms of ocular surface discomfort using medical ice slurry | Jun 13, 2022 | Issued |
Array
(
[id] => 18664904
[patent_doc_number] => 11771769
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-03
[patent_title] => Ocular applications of silk-based products
[patent_app_type] => utility
[patent_app_number] => 17/838566
[patent_app_country] => US
[patent_app_date] => 2022-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 10
[patent_no_of_words] => 90034
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17838566
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/838566 | Ocular applications of silk-based products | Jun 12, 2022 | Issued |
Array
(
[id] => 17850399
[patent_doc_number] => 20220280440
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => METHOD FOR THE MANUFACTURE OF A DOSAGE FORM WITH MUCOADHESIVE PROPERTIES FOR BUCCAL ADMINISTRATION OF BIOLOGICS
[patent_app_type] => utility
[patent_app_number] => 17/751419
[patent_app_country] => US
[patent_app_date] => 2022-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8591
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 322
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17751419
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/751419 | METHOD FOR THE MANUFACTURE OF A DOSAGE FORM WITH MUCOADHESIVE PROPERTIES FOR BUCCAL ADMINISTRATION OF BIOLOGICS | May 22, 2022 | Pending |
Array
(
[id] => 17850438
[patent_doc_number] => 20220280479
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => SELF-EMULSIFYING FORMULATIONS OF DIM-RELATED INDOLES
[patent_app_type] => utility
[patent_app_number] => 17/664105
[patent_app_country] => US
[patent_app_date] => 2022-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44174
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17664105
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/664105 | SELF-EMULSIFYING FORMULATIONS OF DIM-RELATED INDOLES | May 18, 2022 | Abandoned |
Array
(
[id] => 17805670
[patent_doc_number] => 20220257505
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => TREATMENT OF OCULAR DISEASES USING ENDOTHELIN RECEPTOR ANTAGONISTS
[patent_app_type] => utility
[patent_app_number] => 17/733210
[patent_app_country] => US
[patent_app_date] => 2022-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10871
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17733210
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/733210 | TREATMENT OF OCULAR DISEASES USING ENDOTHELIN RECEPTOR ANTAGONISTS | Apr 28, 2022 | Abandoned |
Array
(
[id] => 18724374
[patent_doc_number] => 20230338518
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => Metal Aluminum Nano-Adjuvant, Vaccine Composition And Preparation Method Therefor And Use Thereof
[patent_app_type] => utility
[patent_app_number] => 17/728382
[patent_app_country] => US
[patent_app_date] => 2022-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9009
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17728382
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/728382 | Metal aluminum nano-adjuvant, vaccine composition and preparation method therefor and use thereof | Apr 24, 2022 | Issued |
Array
(
[id] => 17790430
[patent_doc_number] => 20220249521
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => USE OF DERIVATIVES CONTAINING C-O-P BONDS IN PATIENTS WITH KIDNEY FAILURE
[patent_app_type] => utility
[patent_app_number] => 17/728807
[patent_app_country] => US
[patent_app_date] => 2022-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9065
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17728807
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/728807 | USE OF DERIVATIVES CONTAINING C-O-P BONDS IN PATIENTS WITH KIDNEY FAILURE | Apr 24, 2022 | Abandoned |
Array
(
[id] => 17790433
[patent_doc_number] => 20220249524
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => Pharmaceutical formulations comprising 5-Chloro-N4-[2-(dimethylphosphoryl)phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}pyrimidine-2,4-diamine
[patent_app_type] => utility
[patent_app_number] => 17/726736
[patent_app_country] => US
[patent_app_date] => 2022-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11097
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -40
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17726736
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/726736 | Pharmaceutical formulations comprising 5-Chloro-N4-[2-(dimethylphosphoryl)phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}pyrimidine-2,4-diamine | Apr 21, 2022 | Abandoned |
Array
(
[id] => 19423756
[patent_doc_number] => 12083147
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-10
[patent_title] => Compositions and methods for the treatment of contact lens discomfort
[patent_app_type] => utility
[patent_app_number] => 17/723090
[patent_app_country] => US
[patent_app_date] => 2022-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 15127
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17723090
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/723090 | Compositions and methods for the treatment of contact lens discomfort | Apr 17, 2022 | Issued |
Array
(
[id] => 17988804
[patent_doc_number] => 20220354841
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-10
[patent_title] => SUBCUTANEOUS DELIVERY OF POLYMER CONJUGATES OF THERAPEUTIC AGENTS
[patent_app_type] => utility
[patent_app_number] => 17/717666
[patent_app_country] => US
[patent_app_date] => 2022-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32303
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17717666
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/717666 | Subcutaneous delivery of polymer conjugates of therapeutic agents | Apr 10, 2022 | Issued |
Array
(
[id] => 17748129
[patent_doc_number] => 20220226332
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => Phosphodiesterase Inhibitor Treatment
[patent_app_type] => utility
[patent_app_number] => 17/716060
[patent_app_country] => US
[patent_app_date] => 2022-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53390
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 194
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17716060
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/716060 | Phosphodiesterase Inhibitor Treatment | Apr 7, 2022 | Abandoned |
Array
(
[id] => 19032351
[patent_doc_number] => 20240082166
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-14
[patent_title] => ORAL CAPSULE OF PARP INHIBITOR AND PREPARATION METHOD THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/552434
[patent_app_country] => US
[patent_app_date] => 2022-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11982
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18552434
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/552434 | ORAL CAPSULE OF PARP INHIBITOR AND PREPARATION METHOD THEREOF | Mar 24, 2022 | Pending |
Array
(
[id] => 19510449
[patent_doc_number] => 20240342135
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-17
[patent_title] => USE OF NITRATE AND VITAMIN C MICROCAPSULE FOR TREATING SICCA SYNDROME
[patent_app_type] => utility
[patent_app_number] => 18/685073
[patent_app_country] => US
[patent_app_date] => 2022-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5650
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18685073
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/685073 | USE OF NITRATE AND VITAMIN C MICROCAPSULE FOR TREATING SICCA SYNDROME | Mar 24, 2022 | Pending |
Array
(
[id] => 19120088
[patent_doc_number] => 11964049
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-23
[patent_title] => Water soluble compositions and methods of making the same
[patent_app_type] => utility
[patent_app_number] => 17/698896
[patent_app_country] => US
[patent_app_date] => 2022-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 41962
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 262
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17698896
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/698896 | Water soluble compositions and methods of making the same | Mar 17, 2022 | Issued |
Array
(
[id] => 17702740
[patent_doc_number] => 20220202746
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => PHARMACEUTICAL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/694972
[patent_app_country] => US
[patent_app_date] => 2022-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10611
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17694972
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/694972 | Pharmaceutical composition | Mar 14, 2022 | Issued |
Array
(
[id] => 17702670
[patent_doc_number] => 20220202676
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => COMPOSITIONS FOR ALTERING THE COLOR OF HAIR
[patent_app_type] => utility
[patent_app_number] => 17/694821
[patent_app_country] => US
[patent_app_date] => 2022-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15656
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17694821
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/694821 | COMPOSITIONS FOR ALTERING THE COLOR OF HAIR | Mar 14, 2022 | Abandoned |
Array
(
[id] => 17865230
[patent_doc_number] => 20220287965
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-15
[patent_title] => OLEOGELS AND METHODS RELATING THERETO
[patent_app_type] => utility
[patent_app_number] => 17/692288
[patent_app_country] => US
[patent_app_date] => 2022-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6758
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17692288
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/692288 | OLEOGELS AND METHODS RELATING THERETO | Mar 10, 2022 | Pending |